Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Chemo brain hits blood cancer patients too – new study investigates

NCT ID NCT07147621

Knowledge-focused Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at memory, concentration, and language problems caused by chemotherapy in people with blood cancers like leukemia and lymphoma. Researchers will compare 120 patients to their healthy relatives using tests and questionnaires before and after treatment. The goal is to understand how common these cognitive issues are and how they affect quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants in the patient group will be recruited from the Hematology Departments of 2 French academic centers (Angers and Brest University Hospitals). Participants in the control group will be selected among the patient's relatives (family, friends, colleagues, etc.) of the same age category (less than 5 years of difference) and with the same education level.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient group inclusion criteria: * adult patient with acute myeloid leukemia, Hodgkin's lymphoma, or non-Hodgkin's lymphoma; * patient receiving a fixed-duration first-line chemotherapy; * patient affiliated or beneficiary of a social security scheme; .signed inform consent form. * Control group inclusion criteria: * adult; * patient's relative (spouse, brother, sister, friend, etc.); * less than 5 years of difference with the patient; * same educational level (\< baccalaureate/high school degree, baccalaureate/high school degree level, 2-year university degree, \> 2-year university degree); * person affiliated or beneficiary of a social security scheme; * signed informed consent form Exclusion Criteria: * Patient group exclusion criteria: * no patient's relative for the control group; * known or suspective cognitive disorders prior to chemotherapy; * history of severe neurological or psychiatric disorders (e.g., severe depression); .previous chemotherapy; * previous brain radiotherapy; * ongoing treatments affecting cognition; * patient unable to read; * patient not speaking French; * person deprived of liberty by judicial or administrative decision; * person under forced psychiatric care; * person under legal protection measures; * person unable to express consent; .pregnant or breastfeeding woman. * Control group exclusion criteria: * known or suspected cognitive disorders; * history of severe neurological or psychiatric disorder (e.g., severe depression); .previous chemotherapy; * previous brain radiotherapy; * ongoing treatments affecting cognition; * person unable to read; * person not speaking French; * person deprived of liberty by judicial or administrative decision; * person under forced psychiatric care; * person under legal protection measures; * person unable to express consent; * pregnant or breastfeeding woman."

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute myeloid leukemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia Hodgkins lymphoma non-Hodgkin lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute myeloid leukemia Hodgkin&#39;S lymphoma Non-Hodgkin&#39;S lymphoma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospital of Angers

    RECRUITING

    Angers, Maine et Loire, 49933, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.